Author/Creator: Landlinger, C. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Landlinger, C.

1. Affitope-based anti-PCSK9 (proprotein convertase subtilisin/kexin type 9) vaccine (AT04A) reduces atherosclerosis in APOE*3Leiden.CETP mice. (September 2016)

Authors:: Galabova, G.; Juno, C.; van der Hoorn, J.W.A.; Pieterman, E.J.; Pouwer, M.; Landlinger, C.; Jukema, J.W.; Princen, H.M.G.; Staffler, G.
Journal:: Atherosclerosis
Issue:: Volume 252(2016)
Page Start:: e253
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. ON203: A new antibody targeting the oxidized form of macrophage migration inhibitory factor demonstrates antitumorigenic activity in preclinical models. (October 2022)

Authors:: Schinagl, A.; Maurer, B.; Rossmüller, G.; Mirkina, I.; Landlinger, C.; Thiele, M.
Journal:: European journal of cancer
Issue:: Volume 174(2022)Supplement 1
Page Start:: S124
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗